Silk Road Medical Stock Forecast, Price & News

-0.35 (-0.68 %)
(As of 04/15/2021 12:00 AM ET)
Today's Range
Now: $51.30
50-Day Range
MA: $51.41
52-Week Range
Now: $51.30
Volume323,778 shs
Average Volume372,875 shs
Market Capitalization$1.76 billion
P/E RatioN/A
Dividend YieldN/A
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
Silk Road Medical logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:SILK
Year FoundedN/A



Sales & Book Value

Annual Sales$63.35 million
Book Value$2.33 per share


Net Income$-52,420,000.00


Market Cap$1.76 billion
Next Earnings Date4/29/2021 (Estimated)
OptionableNot Optionable


3 Small Caps Ready to Make a Run (SILK)
April 1, 2021 |
Is It Too Late to Buy Silk Road Medical (SILK) Stock?
April 10, 2021 |
Silk Road Medical Becomes Oversold (SILK)
March 29, 2021 |
Bear of the Day: Silk Road Medical (SILK)
March 10, 2021 |
Recap: Silk Road Medical Q4 Earnings
March 1, 2021 |
Silk Road Medical earnings: here's what Wall Street expects
February 27, 2021 |
See More Headlines


Overall MarketRank

1.06 out of 5 stars

Medical Sector

1024th out of 2,021 stocks

Surgical & Medical Instruments Industry

98th out of 169 stocks

Analyst Opinion: 2.3Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
-0.35 (-0.68 %)
(As of 04/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SILK News and Ratings via Email

Sign-up to receive the latest news and ratings for SILK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Silk Road Medical (NASDAQ:SILK) Frequently Asked Questions

Is Silk Road Medical a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Silk Road Medical stock.
View analyst ratings for Silk Road Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Silk Road Medical?

Wall Street analysts have given Silk Road Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Silk Road Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Silk Road Medical?

Silk Road Medical saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 2,180,000 shares, a decrease of 22.7% from the February 28th total of 2,820,000 shares. Based on an average daily volume of 390,100 shares, the short-interest ratio is currently 5.6 days.
View Silk Road Medical's Short Interest

When is Silk Road Medical's next earnings date?

Silk Road Medical is scheduled to release its next quarterly earnings announcement on Thursday, April 29th 2021.
View our earnings forecast for Silk Road Medical

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) posted its quarterly earnings data on Monday, March, 1st. The company reported ($0.49) earnings per share for the quarter, missing analysts' consensus estimates of ($0.28) by $0.21. The company earned $21.10 million during the quarter, compared to analysts' expectations of $21.35 million. Silk Road Medical had a negative trailing twelve-month return on equity of 40.79% and a negative net margin of 53.66%. The firm's revenue was up 13.4% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.27) EPS.
View Silk Road Medical's earnings history

How has Silk Road Medical's stock price been impacted by COVID-19 (Coronavirus)?

Silk Road Medical's stock was trading at $37.14 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SILK shares have increased by 38.1% and is now trading at $51.30.
View which stocks have been most impacted by COVID-19

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical issued an update on its FY 2021 After-Hours earnings guidance on Monday, March, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $102-108 million, compared to the consensus revenue estimate of $111.52 million.

What price target have analysts set for SILK?

4 brokerages have issued 1-year price objectives for Silk Road Medical's stock. Their forecasts range from $55.00 to $75.00. On average, they anticipate Silk Road Medical's share price to reach $61.75 in the next twelve months. This suggests a possible upside of 20.4% from the stock's current price.
View analysts' price targets for Silk Road Medical
or view top-rated stocks among Wall Street analysts.

Who are Silk Road Medical's key executives?

Silk Road Medical's management team includes the following people:
  • Ms. Erica J. Rogers, Pres, CEO & Director (Age 57, Pay $944.91k)
  • Mr. Lucas W. Buchanan, CFO & COO (Age 44, Pay $755.78k)
  • Mr. Andrew S. Davis, Chief Commercial Officer (Age 52, Pay $883.92k)
  • Ms. Mhairi L. Jones, VP of Fin. & Accounting
  • Mr. Matthew McCarthy, VP of Marketing
  • Ms. Alison Highlander, VP of HR
  • Dr. Sumaira MacDonald, Exec. Medical Director
  • Mr. Richard M. Ruedy, Exec. VP of Clinical, Regulatory Affairs & Quality Assurance (Age 54)
  • Dr. William Whealon Ph.D., Exec. VP of R&D
  • Lynn Lewis, Investors Relations Officer

Who are some of Silk Road Medical's key competitors?

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), The Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), Honeywell International (HON), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by many different institutional and retail investors. Top institutional investors include AdvisorNet Financial Inc (0.00%). Company insiders that own Silk Road Medical stock include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg and Richard Ruedy.
View institutional ownership trends for Silk Road Medical

Which major investors are buying Silk Road Medical stock?

SILK stock was bought by a variety of institutional investors in the last quarter, including AdvisorNet Financial Inc.
View insider buying and selling activity for Silk Road Medical
or or view top insider-buying stocks.

How do I buy shares of Silk Road Medical?

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $51.30.

How much money does Silk Road Medical make?

Silk Road Medical has a market capitalization of $1.76 billion and generates $63.35 million in revenue each year. The company earns $-52,420,000.00 in net income (profit) each year or ($1.36) on an earnings per share basis.

How many employees does Silk Road Medical have?

Silk Road Medical employs 281 workers across the globe.

What is Silk Road Medical's official website?

The official website for Silk Road Medical is

Where are Silk Road Medical's headquarters?

Silk Road Medical is headquartered at 1213 INNSBRUCK DR., SUNNYVALE CA, 94089.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at 408-720-9002 or via email at [email protected]

This page was last updated on 4/16/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.